December

ERJ Podcast Eur Respir J 2011; 38: E12
Prof. John Guy Widdicombe, 1925–2011: an appreciation of an eminent respiratory physiologist Chung K.F. Eur Respir J 2011; 38: 1243-1244
Prof. Paul Sadoul, 1918–2011 Puchelle E., Quanjer P.H., Lockhart A., Berglund E., Dinh-Xuan A.T., Widimsky J. Eur Respir J 2011; 38: 1245-1247
Prof. Philippe Godard, 1948–2011 Gaga M., Joos G., Chanez P. Eur Respir J 2011; 38: 1248-1249
New guidelines for the management of adult lower respiratory tract infections Woodhead M. Eur Respir J 2011; 38: 1250-1251
Is it really time to look at distal airways to improve asthma phenotyping and treatment? Perez T. Eur Respir J 2011; 38: 1252-1254
Vitamin D in asthma and allergy: what next? Weiss S.T., Litonjua A.A. Eur Respir J 2011; 38: 1255-1257
Tuberculosis and HIV co-infection: do we have a surveillance system in Europe? Pontali E., Pasticci M.B., Matteelli A., Baldelli F., Migliori G.B. Eur Respir J 2011; 38: 1258-1260
Recommendations for epidemiological studies on COPD Bakke P.S., Rönmark E., Eagan T., Pistelli F., Annesi-Maesano I., Maly M., Meren M., Vermeire† P., Vestbo J., Viegi G., Zielinski J., Lundbäck B. Eur Respir J 2011; 38: 1261-1277
Exposure to thoracic dust, airway symptoms and lung function in cement production workers Nordby K-C., Fell A.K.M., Notø H., Eduard W., Skogstad M., Thomassen Y., Bergamaschi A., Kongerud J., Kjuus H. Eur Respir J 2011; 38: 1278-1286
Biomarkers of early respiratory effects in smoking adolescents Van Miert E., Sardella A., Bernard A. Eur Respir J 2011; 38: 1287-1293
Development of a decision tree to assess the severity and prognosis of stable COPD Esteban C., Arostegui I., Moraza J., Aburto M., Quintana J.M., Pérez-Izquierdo J., Aizpiri S., Capelastegui A. Eur Respir J 2011; 38: 1294-1300
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Fens N., de Nijs S.B., Peters S., Dekker T., Knobel H.H., Vink T.J., Willard N.P., Zwinderman A.H., Krouwels F.H., Janssen H-G., Lutter R., Sterk P.J. Eur Respir J 2011; 38: 1301-1309
Supplementation with vitamin A early in life and subsequent risk of asthma Checkley W., West K.P., Wise R.A., Wu L., LeClerq S.C., Khatry S., Katz J., Christian P., Tielsch J.M., Sommer A. Eur Respir J 2011; 38: 1310-1319
Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study Hollams E.M., Hart P.H., Holt B.J., Serralha M., Parsons F., de Klerk N.H., Zhang G., Sly P.D., Holt P.G. Eur Respir J 2011; 38: 1320-1327
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation Bakker E.M., Volpi S., Salonini E., van der Wiel-Kooij E.C., Sintnicolaas C.J.J.C.M., Hop W.C.J., Assael B.M., Merkus P.J.F.M., Tiddens H.A.W.M. Eur Respir J 2011; 38: 1328-1335
Do responses to exercise training in cystic fibrosis depend on initial fitness level? Gruber W., Orenstein D.M., Braumann K.M. Eur Respir J 2011; 38: 1336-1342
Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension Sandoval J., Gaspar J., Peña H., Santos L.E., Córdova J., del Valle K., Rodríguez A., Pulido T. Eur Respir J 2011; 38: 1343-1348
Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study Marshall N.S., Delling L., Grunstein R.R., Peltonen M., Sjöström C.D., Karason K., Carlsson L.M.S., Hedner J., Stenlöf K., Sjöström L. Eur Respir J 2011; 38: 1349-1354
Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis Tiev K.P., Hua-Huy T., Kettaneh A., Gain M., Duong-Quy S., Tolédano C., Cabane J., Dinh-Xuan A.T. Eur Respir J 2011; 38: 1355-1360
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis Kavuru M.S., Malur A., Marshall I., Barna B.P., Meziane M., Huizar I., Dalrymple H., Karnekar R., Thomassen M.J. Eur Respir J 2011; 38: 1361-1367
Stage IV sarcoidosis: comparison of survival with the general population and causes of death Nardi A., Brillet P-Y., Letoumelin P., Girard F., Brauner M., Uzunhan Y., Naccache J-M., Valeyre D., Nunes H. Eur Respir J 2011; 38: 1368-1373
The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Kruijshaar M.E., Pimpin L., Abubakar I., Rice B., Delpech V., Drumright L.N., Hollo V., Huitric E., van de Laar M., Amato-Gauci A., Manissero D., Ködmön C. Eur Respir J 2011; 38: 1374-1381
Tuberculosis and HIV co-infection in European Union and European Economic Area countries Pimpin L., Drumright L.N., Kruijshaar M.E., Abubakar I., Rice B., Delpech V., Hollo V., Amato-Gauci A., Manissero D., Ködmön C. Eur Respir J 2011; 38: 1382-1392
Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients Whitelaw A., Peter J., Sohn H., Viljoen D., Theron G., Badri M., Davids V., Pai M., Dheda K. Eur Respir J 2011; 38: 1393-1397
Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis Minion J., Leung E., Talbot E., Dheda K., Pai M., Menzies D. Eur Respir J 2011; 38: 1398-1405
Computed tomography measurements of parapneumonic effusion indicative of thoracentesis Moffett B.K., Panchabhai T.S., Anaya E., Nakamatsu R., Arnold F.W., Peyrani P., Wiemken T., Guardiola J., Ramirez J.A. Eur Respir J 2011; 38: 1406-1411
Primary lung adenocarcinoma: characteristics by smoking habit and sex Nagy-Mignotte H., Guillem P., Vesin A., Toffart A.C., Colonna M., Bonneterre V., Brichon P.Y., Brambilla C., Brambilla E., Lantuejoul S., Timsit J.F., Moro-Sibilot D. Eur Respir J 2011; 38: 1412-1419
Predicting survival in malignant mesothelioma Musk A.W., Olsen N., Alfonso H., Reid A., Mina R., Franklin P., Sleith J., Hammond N., Threlfall T., Shilkin K.B., de Klerk N.H. Eur Respir J 2011; 38: 1420-1424
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Hirata T., Yonemori K., Hirakawa A., Shimizu C., Tamura K., Ando M., Katsumata N., Tanimoto M., Fujiwara Y. Eur Respir J 2011; 38: 1425-1430
Relationship between past airway pathology and current lung function in preschool wheezers Sonnappa S., Bastardo C.M., Saglani S., Bush A., Aurora P. Eur Respir J 2011; 38: 1431-1436
High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency van Zeggeren L., van de Ven A.A.J.M., Terheggen-Lagro S.W.J., Mets O.M., Beek F.J., van Montfrans J.M., de Jong P.A. Eur Respir J 2011; 38: 1437-1443
I?B? glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES Seidel P., Roth M., Ge Q., Merfort I., S’ng C.T., Ammit A.J. Eur Respir J 2011; 38: 1444-1452
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Rhodes C.J., Wharton J., Howard L., Gibbs J.S.R., Vonk-Noordegraaf A., Wilkins M.R. Eur Respir J 2011; 38: 1453-1460
Metalloproteinases in idiopathic pulmonary fibrosis Dancer R.C.A., Wood A.M., Thickett D.R. Eur Respir J 2011; 38: 1461-1467
New tools in pulmonary rehabilitation Wijkstra P.J., Wempe J.B. Eur Respir J 2011; 38: 1468-1474
Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study Joshi R., Narang U., Zwerling A., Jain D., Jain V., Kalantri S., Pai M. Eur Respir J 2011; 38: 1475-1477
Microsatellite alterations at 3p and 19q in EBC DNA of smokers: are they reversible after smoking cessation? Carpagnano G.E., Lacedonia D., Palladino G.P., Foschino Barbaro M.P. Eur Respir J 2011; 38: 1477-1480
EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism Park J.S., Chung J-H., Jheon S., Choi D-J., Yoon H.I., Lee J.H., Lee C-T., Lee S.W. Eur Respir J 2011; 38: 1480-1482
Ralstonia mannitolilytica and COPD: a case report Zong Z.Y., Peng C.H. Eur Respir J 2011; 38: 1482-1483
Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated? Gilchrist F.J., France M., Bright-Thomas R., Doherty C.J., Govan J.R., Webb A.K., Jones A.M. Eur Respir J 2011; 38: 1483-1486
Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples Jones A.M., Flight W., Isalska B., Cullen M., Mutton K., Bowling A., Riley D., Webb K., Bright-Thomas R. Eur Respir J 2011; 38: 1486-1487
Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses Morawiec E., Tillie-Leblond I., Pansini V., Salleron J., Remy-Jardin M., Wallaert B. Eur Respir J 2011; 38: 1487-1489
“Impact of maternal asthma on perinatal outcomes.” F. Firoozi, C. Lemière, M-F. Beauchesne, S. Perreault, A. Forget, and L. Blais. Eur Respir J 2011; 38: 1490